CED panel to explore how healthcare changes affect medtech companies

The environment for start-up and early stage medtech companies is challenging and rapidly evolving. Young companies are pursuing their first product approvals in Europe prior to launching products in the United States. This is in part due to the uncertain FDA approval process for 510(k) device approvals, in part due to the new device tax that took effect in 2013, and also due to the shrinking number of venture capital firms that are actively investing in medical device companies. It is also important to consider the sweeping changes in the healthcare industry – the very way that healthcare is...

Read More